CoChat

Magnetocardiography and cardiac risk

Mäkijärvi, M. · 1997 · Herzschrittmachertherapie und Elektrophysiologie

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Risk evaluation is a challenging problem in clinical cardiology. Recently, the development of new therapeutic strategies for malignant cardiac arrhythmias and ischemia has urged the need for more accurate screening methods of risk patients The purpose of this review is to summarize the current scientific evidence on the applicability of a new method, high-resolution magnetocardiography (HR-MCG), in identification of cardiac patients at risk of malignant ventricular arrhythmias and ischemic episodes. In recent years different methods for recognizing the electromagnetic abnormalities indicating the increased risk have been used with promising results. At present, the following conclusions can be made: 1) MCG can reliably identify patients prone to malignant ventricular arrhythmias after myocardial infarction as well as in cardiomyopathy, in long QT syndrome, and in operated congenital heart disease. 2) Several analysis methods seem to work: high-pass filtering, relative smoothness score and magnetic field map trajectory plots. 3) Detection and localization of acute and chronic ischemia seems technically feasible and may be one of the most important new clinical applications of the method. 4) Larger clinical series are needed to optimize these techniques and to evaluate their feasibility in the clinics. 5) Prognostic studies should also be started as soon as possible. There are already many multichannel MCG measurement systems available in hospitals to enable clinical studies.ZUSAMMENFASSUNG: Die Risikoabschätzung stellt in der klinischen Kardiologie ein schwieriges Problem dar. Kürzlich hat die Entwicklung neuer Strategien bei malignen kardialen Arrhythmien und der Ischämie die, Notwendigkeit an exakteren Untersuchungsmethoden bei Risikopatienten unterstrichen. Diese Ubersicht soll dem Zweck dienen, die derzeitige wissenschaftliche Anwendbarkeit einer neuen Methode, der hochauflösenden Magnetokardiographie (HR-MCG) bei Herzpatienten nachzuweisen, bei denen ein Risiko des Auftretens maligner Kammerarrhythmien und ischämischen Episoden beseht. Im Verlauf der letzten Jahre sind mit vielversprechenden Resultaten verschiedene Methoden zum Nachweis elektromagnetischer Störungen entwickelt worden, die auf ein erhöhtes Risiko hinweisen. Momentan können daraus die folgenden Schlussfolgerungen gezogen werden: 1) Die MCG kann das erhöhte Risiko bei den Patienten zuverlässig aufzeigen, die einen Herzinfarkt durchgemacht haben oder an einer Kardiomyopathie, einem langen QT-Syndrom oder einer operierten, kongenitalen Herzerkrankung leiden. 2) Es scheinen verschiedene Auswertungsmethoden zu funktionieren: Hochpassfiltrierung, Relative Smoothness Score und Magnetkarten-Trajektaufzeichnungen. 3) Nachweis und Lokalisation der akuten und chronischen Ischämie erscheinen technisch möglich zu sein und können eine der wichtigsten neuen klinischen Untersuchungsmethoden darstellen. 4) Umfangreichere klinische Studien sind erforderlich, um die Optimierung dieser Methoden zu erreichen und ihre Eignung unter klinischen Bedingungen aufzuzeigen. 5) So bald als möglich sollten ausserdem prognostische Studien eingeleitet werden. Es existieren in Krankenhäusern bereits einige Multikanal-MCG-Messgeräte, die sich zur Durchführung klinischer Studien eignen.

Overview

Integrity signals

Registry

Crossref · 10.1007/bf03042400

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 12 references

Research works printed but not linked: 5

  1. Montonen J, Katila T, Leiniö M, Madekivi S, Mäkijärvi M, Nenonen J, Siltanen P (1987) Time and frequency domain analyses of cardiac micropotentials. In: Atsumi K, Kotani M, Ueno S, Katila T, Williamson SJ (eds) Biomagnetism ’87, Tokyo Denki University Press, Tokyo, pp 278–281
  2. Achenbach S, Moshage W, Flug M, Diem B, Schibgilla V, Bachmann K (1996) Comparison of the ORS duration and RMS40 in signal-averaged recordings of the multichannel MCG to the signal-averaged ECG. Proceedings of the 10th International Conference on Biomagnetism, Sante Fe
  3. Kowalik ZJ, Mäkijärvi M, Wichter T, Fetsch T, Elbert T, Breithardt G, Hoke M (1996) Linear and non-linear analysis in the parallel HR-MCG/HR-ECG experiment in arrhythmogenic right ventricular cardiomyopathy. Proceedings of the 10th International Conference on Biomagnetism, Sante Fe
  4. Seese B, Moshage W, Achenbach S, Killmann R, Bachmann K (1995) Magnetocardiographic (MCG) analysis of myocardial injury currents. In: Baumgartner C, Deecke L, Stroink G, Williamson SJ (eds) Biomagnetism: Fundamental Research and Clinical Applications. Elsevier Science, IOS Press, Amsterdam, pp 628–632.
  5. Leder U, Hemmann A, Eichorn J, Pohl HP, Hoffmann M, Huck MP, Nowak H, Haueisen J, Michaelsen S, Kuhnert H, Muller S (1996) Segmentation of realistically shaped surfaces from 3D MRI for biomagnetic myocardial current imaging. Proceedings of the 10th International Conference on Biomagnetism, Sante Fe

Cited by

Metadata

Authors
Mäkijärvi, M.
Affiliations
Helsinki University Hospital (FI)
Corresponding author
Mäkijärvi, M.
Venue
Herzschrittmachertherapie und Elektrophysiologie
Published
1997-09
Volume
8
Issue
3
Pages
178-183
ISSN
  • 0938-7412 (ISSN-L)
  • 1435-1544
OpenAlex
W200756214
Cited by
3
References
12
Citations by year
2025: 1 · 2023: 1
FWCI
0.00
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Herzschrittmachertherapie + Elektrophysiologie (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › ECG Monitoring and Analysis
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Keywords
cardiac risk assessment, malignant ventricular arrhythmias, myocardial ischemia, myocardial infarction, cardiomyopathy, long QT syndrome, congenital heart disease, high-pass filtering, risk stratification, cardiac screening, prognosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.